title: CML with e6a2 BCR-ABL1 transcript: an aggressive entity?
authors.forename: Karolien Anne
authors.initials: KA
authors.lastname: Beel
authors.forename: Jan
authors.initials: J
authors.lastname: Lemmens
authors.forename: Hilde
authors.initials: H
authors.lastname: Vranckx
authors.forename: Johan
authors.initials: J
authors.lastname: Maertens
authors.forename: Peter
authors.initials: P
authors.lastname: Vandenberghe
mesh_terms: D018450:Disease Progression; D017809:Fatal Outcome; D016044:Fusion Proteins, bcr-abl / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D015321:Gene Rearrangement; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure; D011183:Postoperative Complications / Q000503:physiopathology; D018805:Sepsis / Q000503:physiopathology; D033581:Stem Cell Transplantation
chemical_list: D016044:Fusion Proteins, bcr-abl